Independent Certificates of Analysis aggregated from public lab results. Not affiliated with or paid by Wuhan Wansheng Biotechnology.
| Compound | CoAs | Avg purity | Latest |
|---|---|---|---|
| Retatrutide | 78 | 99.52% | Sep 24, 2026 |
| Tirzepatide | 53 | 99.71% | Sep 4, 2026 |
| Tesamorelin | 27 | 94.35% | Sep 4, 2026 |
| GHK-Cu | 24 | 99.91% | Sep 24, 2026 |
| BPC-157 | 20 | 99.18% | Sep 18, 2026 |
| Ipamorelin | 15 | 99.49% | Sep 4, 2026 |
| Cagrilintide | 14 | 98.57% | May 6, 2026 |
| Melanotan II | 6 | 99.31% | Jul 1, 2026 |
| CJC-1295 No DAC | 5 | 92.66% | Jan 26, 2026 |
| Semaglutide | 5 | 94.88% | Jun 22, 2026 |
| TB-500 | 5 | 96.49% | Mar 25, 2026 |
| PT-141 | 4 | 99.82% | Jan 19, 2026 |
| TB-500 Thymosin Beta-4 | 4 | 94.97% | Sep 18, 2026 |
| CJC-1295 DAC | 2 | 89.94% | Mar 6, 2026 |
| TB-500 Fragment 17-23 | 1 | 99.9% | Mar 6, 2026 |
| Compound | Batch | Purity | Lab | Tested | |
|---|---|---|---|---|---|
| GHK-Cu | CU50WWB062026 | 99.9% | Lab E | Sep 24, 2026 | verify |
| Retatrutide | n/a | 99.9% | Lab E | Sep 24, 2026 | verify |
| BPC-157 | BC20202060620-1 | 97.88% | Lab N | Sep 18, 2026 | verify |
| TB-500 Thymosin Beta-4 | BT2020260620-1 | n/a | Lab N | Sep 18, 2026 | verify |
| Retatrutide | n/a | n/a | Lab K | Sep 16, 2026 | verify |
| Retatrutide | n/a | 99.9% | Lab G | Sep 16, 2026 | verify |
| Retatrutide | RT15WWB072126 | 99.9% | Lab G | Sep 5, 2026 | verify |
| Tirzepatide | TR10WWB062026 | n/a | Lab E | Sep 4, 2026 | verify |
| Tesamorelin | TSM10 | 99.9% | Lab E | Sep 4, 2026 | verify |
| Ipamorelin | n/a | 98.2% | Lab E | Sep 4, 2026 | verify |
| GHK-Cu | CU50WWB062026 | 99.9% | Lab E | Aug 26, 2026 | verify |
| Retatrutide | n/a | 99.9% | Lab E | Aug 26, 2026 | verify |
| Retatrutide | n/a | 99.9% | Lab E | Aug 13, 2026 | verify |
| Retatrutide | RT10WWB052626 | 99.9% | Lab E | Aug 13, 2026 | verify |
| Retatrutide | n/a | 99.9% | Lab G | Aug 2, 2026 | verify |
| Retatrutide | n/a | 99.6% | Lab E | Jul 22, 2026 | verify |
| Retatrutide | n/a | 99.9% | Lab E | Jul 17, 2026 | verify |
| Ipamorelin | IP101020260220-2 | 98.8% | Lab E | Jul 17, 2026 | verify |
| Tirzepatide | n/a | 99.9% | Lab E | Jul 1, 2026 | verify |
| Melanotan II | n/a | 99.9% | Lab E | Jul 1, 2026 | verify |
| Tirzepatide | n/a | 99.8% | Lab G | Jun 26, 2026 | verify |
| Tesamorelin | TSM-2605-1 | 99.9% | Lab E | Jun 24, 2026 | verify |
| BPC-157 | n/a | 99.3% | Lab E | Jun 23, 2026 | verify |
| TB-500 Thymosin Beta-4 | 6.4 | 99.7% | Lab E | Jun 23, 2026 | verify |
| Semaglutide | n/a | 99.9% | Lab E | Jun 22, 2026 | verify |
Showing 25 most recent of 263. Search the full database on the CoA page.
Sell or represent Wuhan Wansheng Biotechnology? Link your customers to this page with the badge below. Free, no signup. The badge and counts update as new lab results land.
<a href="https://ascendpeptide.org/coa/vendor/wuhan-wansheng-biotechnology/" rel="noopener"> <img src="https://ascendpeptide.org/coa/badge/wuhan-wansheng-biotechnology.svg" alt="Wuhan Wansheng Biotechnology: lab tested, 263 CoAs on file at ASCEND Peptide" width="230" height="54"> </a>
Data comes from publicly posted third-party lab certificates (Janoshik, MZ Biolabs, and others) and community submissions. Purity figures are as reported by the testing lab for the specific batch tested; they are not a guarantee of any other batch. For research and informational purposes only.